US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 11.700
  • +0.270+2.36%
Trading Oct 2 14:19 ET
660.18MMarket Cap-4915P/E (TTM)

Astria Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
90.72%28.8M
78.98%24.15M
26.78%67.83M
32.96%19M
63.38%20.24M
31.91%15.1M
-12.26%13.49M
76.23%53.5M
50.29%14.29M
56.82%12.39M
Selling and administrative expenses
34.61%8.09M
54.29%8.42M
33.60%25.7M
56.05%7.33M
47.14%6.9M
24.44%6.01M
8.76%5.46M
29.93%19.24M
23.17%4.7M
14.06%4.69M
-General and administrative expense
34.61%8.09M
54.29%8.42M
33.60%25.7M
56.05%7.33M
47.14%6.9M
24.44%6.01M
8.76%5.46M
29.93%19.24M
23.17%4.7M
14.06%4.69M
Research and development costs
127.85%20.71M
95.77%15.73M
22.95%42.13M
21.65%11.67M
73.27%13.34M
37.36%9.09M
-22.45%8.03M
120.32%34.26M
68.47%9.59M
103.22%7.7M
Operating profit
-90.72%-28.8M
-78.98%-24.15M
-26.78%-67.83M
-32.96%-19M
-63.38%-20.24M
-31.91%-15.1M
12.26%-13.49M
-76.23%-53.5M
-50.29%-14.29M
-56.82%-12.39M
Net non-operating interest income expense
81.81%4.65M
82.72%4.24M
491.71%10.2M
174.75%2.8M
478.26%2.53M
1,094.39%2.56M
4,044.64%2.32M
1,313.11%1.72M
2,984.85%1.02M
1,148.57%437K
Non-operating interest income
81.81%4.65M
82.72%4.24M
491.71%10.2M
174.75%2.8M
478.26%2.53M
1,094.39%2.56M
4,044.64%2.32M
1,313.11%1.72M
2,984.85%1.02M
1,148.57%437K
Other net income (expense)
20.00%-16K
-18.75%-19K
-27,647.27%-15.26M
-169,066.67%-15.21M
62.50%-18K
-33.33%-20K
-1,500.00%-16K
99.97%-55K
156.25%9K
-500.00%-48K
Special income (charges)
----
----
---15.2M
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
--15.2M
----
----
----
----
----
----
----
Other non- operating income (expenses)
20.00%-16K
-18.75%-19K
-12.73%-62K
-188.89%-8K
62.50%-18K
-33.33%-20K
-1,500.00%-16K
5.17%-55K
156.25%9K
-500.00%-48K
Income before tax
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
-52.42%-12M
Income tax
Net income
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
-52.42%-12M
Net income continuous Operations
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
-52.42%-12M
Minority interest income
Net income attributable to the parent company
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
73.41%-51.83M
-39.74%-13.26M
-52.42%-12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-92.36%-24.17M
-78.12%-19.93M
-40.62%-72.89M
-136.82%-31.41M
-47.76%-17.73M
-11.70%-12.57M
26.99%-11.19M
76.37%-51.83M
-39.74%-13.26M
-52.42%-12M
Basic earnings per share
4.44%-0.43
5.00%-0.38
31.83%-2.42
-30.56%-0.94
27.59%-0.63
47.67%-0.45
66.10%-0.4
85.56%-3.55
-122.29%-0.72
-42.62%-0.87
Diluted earnings per share
4.44%-0.43
5.00%-0.38
31.83%-2.42
-30.56%-0.94
27.59%-0.63
47.67%-0.45
66.10%-0.4
85.56%-3.55
-122.29%-0.72
-42.62%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 90.72%28.8M78.98%24.15M26.78%67.83M32.96%19M63.38%20.24M31.91%15.1M-12.26%13.49M76.23%53.5M50.29%14.29M56.82%12.39M
Selling and administrative expenses 34.61%8.09M54.29%8.42M33.60%25.7M56.05%7.33M47.14%6.9M24.44%6.01M8.76%5.46M29.93%19.24M23.17%4.7M14.06%4.69M
-General and administrative expense 34.61%8.09M54.29%8.42M33.60%25.7M56.05%7.33M47.14%6.9M24.44%6.01M8.76%5.46M29.93%19.24M23.17%4.7M14.06%4.69M
Research and development costs 127.85%20.71M95.77%15.73M22.95%42.13M21.65%11.67M73.27%13.34M37.36%9.09M-22.45%8.03M120.32%34.26M68.47%9.59M103.22%7.7M
Operating profit -90.72%-28.8M-78.98%-24.15M-26.78%-67.83M-32.96%-19M-63.38%-20.24M-31.91%-15.1M12.26%-13.49M-76.23%-53.5M-50.29%-14.29M-56.82%-12.39M
Net non-operating interest income expense 81.81%4.65M82.72%4.24M491.71%10.2M174.75%2.8M478.26%2.53M1,094.39%2.56M4,044.64%2.32M1,313.11%1.72M2,984.85%1.02M1,148.57%437K
Non-operating interest income 81.81%4.65M82.72%4.24M491.71%10.2M174.75%2.8M478.26%2.53M1,094.39%2.56M4,044.64%2.32M1,313.11%1.72M2,984.85%1.02M1,148.57%437K
Other net income (expense) 20.00%-16K-18.75%-19K-27,647.27%-15.26M-169,066.67%-15.21M62.50%-18K-33.33%-20K-1,500.00%-16K99.97%-55K156.25%9K-500.00%-48K
Special income (charges) -----------15.2M------------------0--------
-Less:Other special charges ----------15.2M----------------------------
Other non- operating income (expenses) 20.00%-16K-18.75%-19K-12.73%-62K-188.89%-8K62.50%-18K-33.33%-20K-1,500.00%-16K5.17%-55K156.25%9K-500.00%-48K
Income before tax -92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M-52.42%-12M
Income tax
Net income -92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M-52.42%-12M
Net income continuous Operations -92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M-52.42%-12M
Minority interest income
Net income attributable to the parent company -92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M73.41%-51.83M-39.74%-13.26M-52.42%-12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -92.36%-24.17M-78.12%-19.93M-40.62%-72.89M-136.82%-31.41M-47.76%-17.73M-11.70%-12.57M26.99%-11.19M76.37%-51.83M-39.74%-13.26M-52.42%-12M
Basic earnings per share 4.44%-0.435.00%-0.3831.83%-2.42-30.56%-0.9427.59%-0.6347.67%-0.4566.10%-0.485.56%-3.55-122.29%-0.72-42.62%-0.87
Diluted earnings per share 4.44%-0.435.00%-0.3831.83%-2.42-30.56%-0.9427.59%-0.6347.67%-0.4566.10%-0.485.56%-3.55-122.29%-0.72-42.62%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data